NgG investigational vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NgG investigational vaccine, covering 2026-06-16 to 2026-06-16. Get the full timeline:
Most recent: Clinical Trial Results: Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age [Phase 1, Phase 2]